ARTICLE | Company News
Grifols acquires 44% minority stake in GigaGen for $35M
July 28, 2017 7:52 PM UTC
On July 5, Grifols S.A. (Madrid:GRF; NASDAQ:GRFS) acquired a 44% stake in GigaGen Inc. (San Francisco, Calif.) for $35 million. GigaGen's assets include a platform that combines yeast protein expression and repertoire mining to produce diverse antibody libraries. GigaGen's preclinical portfolio includes a recombinant immunoglobin therapy as well as immuno-oncology therapies...